Designing a research agenda to improve the quality of emergency care

Academic Emergency Medicine

Volumn 9, Issue 11, 2002, Pages 1124-1130

  Magid, David J ^a   Rhodes, Karin V ^a   Asplin, Brent R ^a   Steiner, John F ^a   Rumsfeld, John S ^a  

^a CLINICAL RESEARCH UNIT   (United States)

Author keywords

Emergency medicine; Quality; Research

Indexed keywords

FIBRINOLYTIC AGENT;

BRAIN HEMORRHAGE; CLINICAL PRACTICE; CONFERENCE PAPER; EMERGENCY HEALTH SERVICE; ERROR; FIRST AID; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT;

EMERGENCY MEDICAL SERVICES; EMERGENCY MEDICINE; EMERGENCY TREATMENT; HEALTH SERVICES RESEARCH; HUMANS; QUALITY OF HEALTH CARE;

EID: 0036843931     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/aemj.9.11.1124     Document Type: Article

References (64)

1. Committee on Quality on Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press, 2001.
2. RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990; 336:827-30.
3. ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction. Lancet. 1988; 2:349-60.
4. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation, Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Bethesda, MD/Dallas, TX: ACC/AHA, 2002.
5. Ryan TJ, Antman EM, Brooks NH, et al. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: 1999 Update: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Bethesda, MD/Dallas, TX: ACC/AHA, 1999.
6. Ellerbeck EF, Jencks SF, Radford MJ, et al., for the Cooperative Cardiovascular Project. Quality of care for Medicare patients with myocardial infarction: A four-state pilot study. JAMA. 1995; 273:1509-14.
7. McLaughlin TJ, Soumerai SB, Wilson DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction. Arch Intern Med. 1996; 156:799-805.
8. Saketkhou BB, Conte FJ, Noris M, et al. Emergency department use of aspirin in patients with possible acute myocardial infarction. Ann Intern Med. 1997; 127:126-9.
9. Soumerai SB, McLaughlin TJ, Gurwitz J. Effect of local opinion leaders on quality of care for acute myocardial infarction. JAMA. 1998; 279:1358-63.
10. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction. The Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002; 287:1269-76.
11. Callaham M. Quantifying the scanty science of prehospital emergency care. Ann Emerg Med. 1997; 30:785-90.
12. National Heart, Lung, and Blood Institute. Website: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed 2001.
13. Burstin HR, Conn A, Setnik G, et al. Benchmarking and quality improvement: The Harvard Emergency Department Quality Study. Am J Med. 1999; 107:437-49.
14. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994; 343:311-22.
15. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation. 1999; 100:14-20.
16. Rawles JM. Quantification of the benefit of earlier thrombolytic therapy: Five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol. 1997; 30:1181-6.
17. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283:2941-7.
18. Hedges JR, Feldman HA, Bittner V, et al. Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: Rapid Early Action for Coronary Treatment (REACT) trial. REACT Study Group. Acad Emerg Med. 2000; 7:862-72.
19. Caputo RP, Ho KK, Stoler RC, et al. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1997; 79:1159-64.
20. Saturno PJ, Felices F, Segura J, Vera A, Rodriguez JJ. Reducing time delay in the thrombolysis of myocardial infarction: An internal quality improvement project. ARIAM Project Group. Analisis del Retraso en Infarto Agudo de Miocardio. Am J Med Qual. 2000; 15:85-93.
21. Guidry UA, Paul SD, Vega J, et al. Impact of a simple inexpensive quality assurance effort on physician's choice of thrombolytic agents and door-to-needle time: Implication for costs of management. J Thromb Thrombolysis. 1998; 5:151-7.
22. Eisenberg MS, Mengert TJ. Cardiac resuscitation. N Engl J Med. 2001; 344:1304-13.
23. Spaite DW, Bartholomeaux F, Guisto J, et al. Rapid process redesign in a university-based emergency department: Decreasing waiting time intervals and improving patient satisfaction. Ann Emerg Med. 2002; 39:168-77.
24. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes RJ. National Academy of Clinical Biochemistry Standards of Laboratory Practice recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999; 45:1104-21.
25. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: Is MB creatine kinase the choice for the 1990s? Circulation. 1993; 88:750-63.
26. Ellis AK. Serum protein measurements and the diagnosis of acute myocardial infarction. Circulation. 1991; 83:1107-9.
27. Roberts R, Kleiman NS. Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a "new diagnostic mind-set." Circulation. 1994; 89:872-81.
28. Stiell IG, Greenberg GH, McKnight RD, et al. Decision rules for the use of radiography in acute ankle injuries. Refinement and prospective validation. JAMA. 1993; 269:1127-32.
29. Stiell IG, Greenberg GH, Wells GA, et al. Prospective validation of a decision rule for the use of radiography in acute knee injuries. JAMA. 1996; 275:611-5.
30. Stiell IG, Wells GA, Vandemheen K, et al. The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001; 357:1391-6.
31. Stiell IG, Wells GA, Vandemheen KL, et al. The Canadian C-spine Rule for radiography in alert and stable trauma patients. JAMA. 2001; 286:1841-8.
32. Hoffman JR, Mower WR, Wolfson AB, Todd KH, Zucker MI. Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma. National Emergency X-Radiography Utilization Study Group. N Engl J Med. 2000; 343:94-9.
33. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336:243-50.
34. Farkouh ME, Smars PA, Reeder GS, et al. The Chest Pain Evaluation in the Emergency Room (CHEER) Investigators - A Clinical Trial of a Chest-Pain Observation Unit for Patients with Unstable Angina. N Engl J Med. 1998; 339:1882-8.
35. Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press, 2000.
36. Gore JM, Sloan M, Price T, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infartion, Phase II, pilot and clinical trial. Circulation. 1991; 83:448-59.
37. Richards CF, Cannon CP. Reducing medication errors: Potential benefits of bolus thrombolytic agents. Acad Emerg Med. 2000; 7:1285-9.
38. Gurwitz JH, Gore JM, Goldberg R, et al. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Ann Int Med. 1998; 129:597-604.
39. Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care. 2000; 38:261-71.
40. Leape LL, Brennan TA, Laird NM, et al. The nature of adverse events in hospitalized patients: Results from the Harvard Medical Practice Study II. N Engl J Med. 1991; 324:377-84.
41. Leape LL. The preventability of medical injury. In: Bognor MS (ed). Human Error in Medicine. Hillsdale, NJ: Lawrence Erlbaum Associates, 1994.
42. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard Medical Practice Study. N Engl J Med. 1991; 324:370-6.
43. Vincent C, Simon R, Sutcliffe K, Adams JG, Biros MH, Wears RL. Errors conference: Executive summary. Acad Emerg Med. 2000; 7:1180-2.
44. Handler JA, Gillam M, Sanders AB, Klasco R. Defining, identifying, and measuring error in emergency medicine. Acad Emerg Med. 2000; 7:1183-8.
45. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000; 342:1163-70.
46. Bursch B, Breezy J, Shaw R. Emergency department satisfaction: What matters most? Ann Emerg Med. 1993; 22:586-91.
47. Sun BC, Adams JG, Burstin HR. Validating a model of patient satisfaction with emergency care. Ann Emerg Med. 2001; 38:527-32.
48. Fosnocht DE, Swanson ER, Bossart P. Patient expectations for pain medication delivery. Am J Emerg Med. 2001; 19:399-402.
49. Douglass J, Aroni R, Goeman D, et al. A qualitative study of action plans for asthma. BMJ. 2002; 324:1003-5.
50. Nerney MP, Chin MH, Jin L, et al. Factors associated with older patients' satisfaction with care in an inner-city emergency department. Ann Emerg Med. 2001; 38:140-5.
51. Bordreaux ED, Ary RD, Mandry CV, McCabe B. Determinants of patient satisfaction in a large, municipal ED: The role of demographic variables, visit characteristics, and patient perceptions. Am J Emerg Med. 2000; 18:394-400.
52. Trout A, Magnusson AR, Hedges JR. Patient satisfaction investigations and the emergency department: What does the literature say? Acad Emerg Med. 2000; 7:695-709.
53. Rovelli F, Devita C, Feruglio GA, et al. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction: Gruppo Italiano per lo Studio Della Streptochinasi 'nell Infarto miocardico (GISSI). Lancet. 1986; 1:397-402.
54. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329:673-82.
55. Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993; 328:685-91.
56. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993; 328:673-9.
57. Zijlstra F, de Boer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993; 328:680-4.
58. Yarzebski J, Col N, Pagley P, Savangeau J, Gore J, Goldberg R. Gender differences and factors associated with receipt of thrombolytic therapy in patients with acute myocardial infarction: A community-wide perspective. Am Heart J. 1996; 131:43-50.
59. Gurwitz JH, Gore JM, Goldberg RJ. Recent age-related trends in the use of thrombolytic therapy in patients who had had acute myocardial infarction. Ann Intern Med. 1996; 124:283-91.
60. Allison JJ, Kiefe CI, Centor RM, Box JB, Farmer RM. Racial differences in the medical treatment of elderly Medicare patients with acute myocardial infarction. J Gen Intern Med. 1996; 11:736-43.
61. Todd KH, Deaton C, D'Adamo AP, Goe L. Ethnicity and analgesic practice. Ann Emerg Med. 2000; 35:11-6.
62. Todd KH. Pain assessment and ethnicity. Ann Emerg Med. 1996; 27:421-3.
63. Todd KH, Lee T, Hoffman JR. The effect of ethnicity on physician estimates of pain severity in patients with isolated extremity trauma. JAMA. 1994; 271:925-8.
64. VanRyn M. Research on the provider contributions to race/ethnicity disparities in medical care. Med Care. 2000; 40:I-140-I 151.